Latest filing published 11 Jun 2024 for Zomedica Corp., €3,528.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -69.1%Entry US$0.15 · Close at T+365 US$0.05
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Peter Donato: trading record in brief
Peter Donato has filed trades across 3 companies (mainly through SEC (Form 4)), most often in Iris International Inc, Neuronetics, Inc. and Zomedica Corp. The record holds 61 filings, for trades running from 4 March 2008 to 10 June 2024.
The open-market side counts 1 purchase for €3,528 alongside 50 sales for €872k. Netting one side against the other leaves €868k of net selling. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 3 share grants and 5 option exercises. 2024 to date brings 1 purchase and no sales.
On 11 June 2024 came the latest disclosure, an open-market purchase for €3,528 in Zomedica Corp. Typically, a trade is published a median of 1 day after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Peter Donato
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 25,000 shares@ US$0.1519100.0% of flowCommon Stock, without par valueSEC:0001654954-24-007615:0Canonical exit: 8 Sept 2024 (T+90)
- 563 shares@ US$15.400.8% of flowCommon StockSEC:0001209191-19-029741:0
- 8,032 shares@ US$14.9010.8% of flowCommon StockSEC:0001209191-19-029741:1
- 6,905 shares@ US$2.321.4% of flowCommon StockSEC:0001209191-19-029440:0
- 7,672 shares@ US$4.643.2% of flowCommon StockSEC:0001209191-19-029440:1
- 24,051 shares@ US$3.196.9% of flowCommon StockSEC:0001209191-19-029440:2
- 20,469 shares@ US$15.2328.0% of flowCommon StockSEC:0001209191-19-029440:3
- 1,878 shares@ US$15.672.6% of flowCommon StockSEC:0001209191-19-029440:4
- 706 shares@ US$15.301.0% of flowCommon StockSEC:0001209191-19-029440:5
- 14,007 sharesCommon StockSEC:0001209191-19-018606:4
- 18,061 shares@ US$3.195.1% of flowCommon StockSEC:0001209191-19-018606:0
- 18,061 shares@ US$16.2126.1% of flowCommon StockSEC:0001209191-19-018606:1
- 8,177 shares@ US$3.192.3% of flowCommon StockSEC:0001209191-19-018606:2
- 8,177 shares@ US$16.0111.8% of flowCommon StockSEC:0001209191-19-018606:3
- 100 shares@ US$11.42Common StockSEC:0001140361-10-019268:0
- 100 shares@ US$11.45Common StockSEC:0001140361-10-019268:1
- 100 shares@ US$11.48Common StockSEC:0001140361-10-019268:2
- 100 shares@ US$11.49Common StockSEC:0001140361-10-019268:3
- 186 shares@ US$11.55Common StockSEC:0001140361-10-019268:4
- 146 shares@ US$10.39Common StockSEC:0001140361-10-012156:0
- 146 shares@ US$10.40Common StockSEC:0001140361-10-012156:1
- 146 shares@ US$10.41Common StockSEC:0001140361-10-012156:3
- 146 shares@ US$10.42Common StockSEC:0001140361-10-012156:4
- 146 shares@ US$10.44Common StockSEC:0001140361-10-012156:6
- 146 shares@ US$10.52Common StockSEC:0001140361-10-012156:7
25 of 58 declarations
